Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review.

Journal of the European Academy of Dermatology and Venereology : JEADV - 1 Jul 2020

Al-Janabi A, Foulkes A C, Mason K, Smith C H, Griffiths C E M, Warren R B

Abstract excerpt

The use of biologic therapies for the treatment of chronic plaque psoriasis has been linked to the development of atopic eczema, amongst other cutaneous adverse events. This can cause diagnostic confusion and create difficulty in the management of patients with plaque psoriasis. The main objective of this systematic review was to review all cases of eczema, including atopic eczema, reported in patients treated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Biological Products

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Eczema

Share to Phenotype

Share to Psoriasis

Source

Identifiers

PMID: 31997406
DOI: 10.1111/jdv.16246

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review.PMID 31997406Read ↗

Dupilumab-induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin-17A expression: a case report.Semantic proximity Read ↗

Novel biologic therapies for psoriasis.Semantic proximity Read ↗

Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis.Semantic proximity Read ↗

Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients.Semantic proximity Read ↗

Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy.Semantic proximity Read ↗

Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic BiomarkersSemantic proximity Read ↗

Complementary Use of a Next-Generation Emollient Plus and Pimecrolimus in Atopic Dermatitis: A Case ReportSemantic proximity Read ↗

New-Onset Guttate Psoriasis: A Long-Term Follow-Up Study.Semantic proximity Read ↗

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.